Towards Healthcare
U.S. Pharmaceutical Water Market to Reach USD 17.04 Bn by 2034

U.S. Pharmaceutical Water Market Trends Highlight WFI Dominance

Market insights predict, the U.S. pharmaceutical water industry is expected to grow from USD 7.11 billion in 2024 to USD 17.04 billion by 2034, driven by a CAGR of 8.94%. Rising demand for injectable drugs, vaccines, biologics, and biosimilars, which require ultra-pure water like Water for Injection(WFI), has driven the growth of the market.

Content

  • Insight Code: 6238
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The U.S. pharmaceutical water market is valued at USD 7.75 billion in 2025 and is on track to reach USD 17.04 billion by 2034, witnessing a steady CAGR of 8.94% during the forecast span.

Northeast / Mid-Atlantic is leading the U.S. pharmaceutical water market due to the growing research & development activities, increasing demand for biologics, and the presence of key players.

The U.S. pharmaceutical water market includes six segments including by water type/product type, by application/end use, by technology/generation & treatment platform, by end user/buyer type, by solution/business model, and by region.

Key trends include the rising adoption of inorganic growth strategies and investment & funding activities.

American Pharmacists Association (APhA), Food and Drug Administration, Pharmaceutical Research and Manufacturers of America (PhRMA), clinicaltrials.gov, American Association of Pharmaceutical Scientists (AAPS), and U.S. Pharmacopeia (USP), among others.
Any Questions